Acrivon Therapeutics Inc. (ACRV)
NASDAQ · Healthcare
Acrivon Therapeutics Inc. Net Income 2020–2025
Acrivon Therapeutics Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Acrivon Therapeutics Inc. net income for the quarter ending March 31, 2026 was -19.0 M.
- Acrivon Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -77.3 M.
- Acrivon Therapeutics Inc. annual net income for 2025 was -77.9 M, a 3.29% decrease from 2024.
- Acrivon Therapeutics Inc. annual net income for 2024 was -80.6 M, a 33.40% increase from 2023.
- Acrivon Therapeutics Inc. annual net income for 2023 was -60.4 M, a 93.76% increase from 2022.
- Acrivon Therapeutics Inc. annual net income for 2022 was -31.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Acrivon Therapeutics Inc. Net Income — FAQ
Acrivon Therapeutics Inc. (ACRV) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Acrivon Therapeutics Inc.'s net income?
Acrivon Therapeutics Inc. (ACRV) reported net income of -$78M for fiscal 2025.
Where can I see ACRV's net income history?
The chart and table above show Acrivon Therapeutics Inc.'s net income by year and by quarter, including the growth rate.